The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian ...

Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This ...

Greg Herbruck knew 6.5 million of his birds needed to die, and fast. But the CEO of Herbruck's Poultry Ranch wasn't sure how ...

AIM ImmunoTech Inc. announced plans to advance its drug Ampligen as a vaccine adjuvant for avian influenza, marking a new initiative in its antiviral development pipeline. The company has ...

Person-to-person transmission remains rare, but Dr. David Hirschwerk provides insight into how to protect yourself from Avian ...

The organization is now seeking collaboration with companies, manufacturers, and research institutions to accelerate vaccine development. Why Avian Influenza Is a Growing Threat Avian influenza ...

The Indian Council of Medical Research (ICMR) has begun the process of development of a vaccine against the deadly and highly-pathogenic H5N1 virus, also called avian influenza.

Investing.com -- AIM ImmunoTech (NYSE:AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

Neither of the two strains of avian influenza that have infected dairy cows in the United States have been detected in the ...